+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Automated Oligonucleotide Synthesizer Market by Product Type, Application, Technology, End User, Scale - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081163
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Amid rapid advancements in life sciences, the automated oligonucleotide synthesizer market is entering a new phase defined by next-generation instrumentation, evolving service models, and shifting regulatory landscapes. Decision-makers face expanding opportunities, driven by increased demand for precision genetic tools and operational efficiency gains across diverse user segments.

Market Snapshot: Automated Oligonucleotide Synthesizer Market

The automated oligonucleotide synthesizer market demonstrates robust momentum, with industry stakeholders recognizing automated platforms as essential to contemporary biotechnology workflows. Market valuations and growth rates reflect accelerating adoption in both established and emerging segments. Innovation in reagent formulations, platform scalability, and digital integration are reshaping value propositions for both manufacturers and end users.

Scope & Segmentation

This comprehensive report provides in-depth segmentation and regional analysis to guide strategic planning and resource allocation:

  • Product Types: Consumables, Instruments, Services
  • Consumables: Phosphoramidites, Reagent Solvents, Solid Supports
  • Instruments: Benchtop Synthesizer, High Throughput Synthesizer
  • Services: Custom Synthesis, Maintenance, Training
  • Applications: DNA Synthesis (Primer, Probe, Synthetic Gene), RNA Synthesis (miRNA, mRNA, siRNA), Therapeutic Oligonucleotides (Antisense, Aptamer, siRNA Therapeutics)
  • Technologies: Enzymatic Synthesis, Phosphoramidite Synthesis
  • End Users: Academic Institutions, Biotechnology Companies, Contract Manufacturing Organizations, Contract Research Organizations, Pharmaceutical Companies
  • Scale: Benchtop, High Throughput
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (selected countries), Asia-Pacific (China, India, Japan, Australia, and others)
  • Leading Companies: Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Tecan Group, Hamilton Company, Gilson, BioAutomation, Biosearch Technologies, CEM Corporation, Hitachi High-Tech Corporation

Key Takeaways for Decision-Makers

  • Automated oligonucleotide synthesizers have shifted from specialty instruments to must-have assets, supporting workflows from gene synthesis to therapeutic development.
  • Blurring of boundaries between hardware vendors and custom service providers is expanding access points and enabling new collaboration models across the value chain.
  • Emerging enzymatic synthesis methods promise environmental and cost advantages, complementing established phosphoramidite chemistry.
  • The move to modular, high-throughput platforms is enhancing scalability and enabling unified synthesis, purification, and quality control in a single system.
  • Service innovation—including tailored maintenance, onboarding, and training—drives lasting value and recurring engagement for vendors targeting enterprise customers.

Tariff Impact and Resilience Strategies

Beginning in 2025, new tariffs on specialized reagents and components are introducing cost pressures for manufacturers and end users. Market participants are responding by localizing reagent supply chains, adapting procurement strategies, and exploring pricing flexibility to safeguard customer relationships. Diversification of supplier networks and emphasis on domestic partnerships are emerging as preferred approaches to maintain business continuity and supply stability while addressing evolving trade requirements.

Automated Oligonucleotide Synthesizer Market: Methodology & Data Sources

The analysis is grounded in a two-tier research methodology. Primary inputs were secured through interviews with executives and functional managers from academic, biotechnology, and pharmaceutical sectors. Secondary validation leveraged industry conference materials, regulatory filings, patent analyses, and peer-reviewed publications. Data triangulation and peer review processes were rigorously applied to ensure accuracy, context, and objective insight.

Why This Report Matters

  • Enables senior leaders to align investments with the fastest-growing applications and technologies across global regions.
  • Supports risk mitigation by providing clear strategies for navigating tariff fluctuations and emerging sourcing challenges.
  • Empowers executive stakeholders to optimize resource allocation, respond to shifting partnerships, and capitalize on regional growth drivers.

Conclusion

The automated oligonucleotide synthesizer landscape is evolving rapidly, with market dynamics favoring organizations that quickly adapt to new technologies, resilient supply frameworks, and integrated service offerings. Well-informed strategies grounded in clear market insights will be key to securing a competitive edge in this advancing sector.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automated Oligonucleotide Synthesizer Market, by Product Type
8.1. Introduction
8.2. Consumables
8.2.1. Phosphoramidites
8.2.2. Reagents Solvents
8.2.3. Solid Supports
8.3. Instruments
8.3.1. Benchtop Synthesizer
8.3.2. High Throughput Synthesizer
8.4. Services
8.4.1. Custom Synthesis Service
8.4.2. Maintenance Service
8.4.3. Training Service
9. Automated Oligonucleotide Synthesizer Market, by Application
9.1. Introduction
9.2. DNA Synthesis
9.2.1. Primer Synthesis
9.2.2. Probe Synthesis
9.2.3. Synthetic Gene Synthesis
9.3. RNA Synthesis
9.3.1. miRNA Synthesis
9.3.2. mRNA Synthesis
9.3.3. siRNA Synthesis
9.4. Therapeutic Oligonucleotides
9.4.1. Antisense Oligonucleotides
9.4.2. Aptamer Development
9.4.3. siRNA Therapeutic
10. Automated Oligonucleotide Synthesizer Market, by Technology
10.1. Introduction
10.2. Enzymatic Synthesis
10.3. Phosphoramidite Synthesis
11. Automated Oligonucleotide Synthesizer Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Biotechnology Companies
11.4. Contract Manufacturing Organizations
11.5. Contract Research Organizations
11.6. Pharmaceutical Companies
12. Automated Oligonucleotide Synthesizer Market, by Scale
12.1. Introduction
12.2. Benchtop
12.3. High Throughput
13. Americas Automated Oligonucleotide Synthesizer Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Automated Oligonucleotide Synthesizer Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Automated Oligonucleotide Synthesizer Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Agilent Technologies, Inc.
16.3.4. Tecan Group Ltd.
16.3.5. Hamilton Company, Inc.
16.3.6. Gilson, Inc.
16.3.7. BioAutomation, LLC.
16.3.8. Biosearch Technologies, Inc.
16.3.9. CEM Corporation
16.3.10. Hitachi High-Tech Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET MULTI-CURRENCY
FIGURE 2. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET MULTI-LANGUAGE
FIGURE 3. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REAGENTS SOLVENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOLID SUPPORTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BENCHTOP SYNTHESIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HIGH THROUGHPUT SYNTHESIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CUSTOM SYNTHESIS SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MAINTENANCE SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TRAINING SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRIMER SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PROBE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SYNTHETIC GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MIRNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MRNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SIRNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APTAMER DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SIRNA THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHOSPHORAMIDITE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HIGH THROUGHPUT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 75. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 76. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 77. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 79. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 80. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 81. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 86. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 92. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 140. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 142. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 143. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 144. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 146. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 147. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 148. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 151. FRANCE AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. FRANCE AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 153. FRANCE AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 154. FRANCE AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 155. FRANCE AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. FRANCE AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 157. FRANCE AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 158. FRANCE AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 159. FRANCE AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. FRANCE AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. FRANCE AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 173. ITALY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. ITALY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 175. ITALY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 176. ITALY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 177. ITALY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. ITALY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 179. ITALY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 180. ITALY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 181. ITALY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. ITALY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. ITALY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 184. SPAIN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. SPAIN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 186. SPAIN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 187. SPAIN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 188. SPAIN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. SPAIN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 190. SPAIN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 191. SPAIN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 192. SPAIN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. SPAIN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SPAIN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 228. DENMARK AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. DENMARK AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 230. DENMARK AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. DENMARK AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 232. DENMARK AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. DENMARK AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 234. DENMARK AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 235. DENMARK AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 236. DENMARK AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. DENMARK AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. DENMARK AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 250. QATAR AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. QATAR AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 252. QATAR AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 253. QATAR AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 254. QATAR AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. QATAR AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 256. QATAR AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 257. QATAR AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 258. QATAR AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. QATAR AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. QATAR AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 261. FINLAND AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. FINLAND AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 263. FINLAND AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 264. FINLAND AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 265. FINLAND AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. FINLAND AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 267. FINLAND AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 268. FINLAND AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 269. FINLAND AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. FINLAND AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. FINLAND AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Automated Oligonucleotide Synthesizer market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Tecan Group Ltd.
  • Hamilton Company, Inc.
  • Gilson, Inc.
  • BioAutomation, LLC.
  • Biosearch Technologies, Inc.
  • CEM Corporation
  • Hitachi High-Tech Corporation